Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension
Stopped Lower than anticipated enrollment
Conditions
Interventions
- BIOLOGICAL: Placebo followed by Autologous EPCs transfected with human eNOS
- BIOLOGICAL: Autologous EPCs transfected with human eNOS followed by Placebo
- BIOLOGICAL: Autologous EPCs transfected with human eNOS
Sponsor
Northern Therapeutics
Collaborators